0001209191-24-001741.txt : 20240117 0001209191-24-001741.hdr.sgml : 20240117 20240117160525 ACCESSION NUMBER: 0001209191-24-001741 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240112 FILED AS OF DATE: 20240117 DATE AS OF CHANGE: 20240117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Semerjian Harout CENTRAL INDEX KEY: 0001809747 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36177 FILM NUMBER: 24538442 MAIL ADDRESS: STREET 1: 300 THE AMERICAN ROAD STREET 2: C/O IMMUNOMEDICS, INC. CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLYCOMIMETICS INC CENTRAL INDEX KEY: 0001253689 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9708 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-243-1201 MAIL ADDRESS: STREET 1: 9708 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-12 0 0001253689 GLYCOMIMETICS INC GLYC 0001809747 Semerjian Harout C/O GLYCOMIMETICS, INC 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 1 1 0 0 Chief Executive Officer 0 Employee Stock Option (right to buy) 3.11 2024-01-12 4 A 0 695000 0.00 A 2034-01-11 Common Stock 695000 695000 D 25% of the shares underlying this option will vest on January 12, 2025 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date. /s/ Brian F. Leaf, attorney-in-fact 2024-01-17